BCL2L11 and hepatocellular carcinoma: reported that the transactivation of ERK signaling and RAF dimer formation enhance HCC cell survival, inhibit apoptosis by downregulating Bim, and mitigate immunosuppression through the activation of PD‐L1 gene expression [17].